The prognostic impact of psychotropic drugs in intentional drug overdose

Pharmacopsychiatry

Volumn 42, Issue 2, 2009, Pages 51-56

  Tournier, M ^a   Grolleau, A ^a   Cougnard, A ^a   Verdoux, H ^a   Molimard, M ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMIC ACID; HYPNOTIC SEDATIVE AGENT; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SELF POISONING; CAUSE OF DEATH; HOSPITALIZATION; INTOXICATION; MIDDLE AGED; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR; SUICIDE ATTEMPT;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CARBAMATES; CAUSE OF DEATH; COHORT STUDIES; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OVERDOSE; PROGNOSIS; PSYCHOTROPIC DRUGS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED;

EID: 67649158698     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1100426     Document Type: Article

References (30)

1. Baca-Garcia E, Diaz-Sastre C, Saiz-Ruiz J et al. How safe are psychiatric medications after a voluntary overdose? Eur Psychiatry 2002 ; 17 : 466-470
2. Buckley NA, Dawson AH, Whyte IM et al. An analysis of age and gender influences on the relative risk for suicide and psychotropic drug selfpoisoning . Acta Psychiatr Scand 1996 ; 93 : 168-171
3. Caisse nationale de l ' Assurance Maladie. Dossier MEDIC ' Assurance Maladie 2006. In: Caisse nationale de l ' Assurance Maladie. Paris ; 2007
4. Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol 2000 ; 3 : 51-54
5. Haro L de, Roelandt J, Pommier P et al. Aetiologies of lithium overdose: 10-year experience of Marseille poison centre. Ann Fr Anesth Reanim 2003 ; 22 : 514-519
6. Doshi A, Boudreaux ED, Wang N et al. National study of US emergency department visits for attempted suicide and self-inflicted injury, 1997 - 2001. Ann Emerg Med 2005 ; 46 : 369-375
7. European Pharmaceutical Marketing Research Association (EphMRA). The Anatomical Classification of Pharmaceutical Products 2006 ; http://www.ephmra. org/main.asp
8. Gunnell D, Hawton K, Murray V et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health 1997 ; 51 : 175-179
9. Hawton K, Simkin S, Deeks J et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004 ; 329 : 1076
10. Hawton K, Townsend E, Deeks J et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 2001 ; 322 : 1203-1207
11. Lamprecht HC, Pakrasi S, Gash A et al. Deliberate self-harm in older people revisited. Int J Geriatr Psychiatry 2005 ; 20 : 1090-1096
12. Litovitz TL, Klein-Schwartz W, White S et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2001 ; 19 : 337-395
13. Mason J, Freemantle N, Eccles M. Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract 2000 ; 50 : 366-370
14. Matsika MD, Tournier M, Lagnaoui R et al. Comparison of patient questionnaires and plasma assays in intentional drug overdoses. Basic Clin Pharmacol Toxicol 2004 ; 95 : 31-37
15. Moore N, Briffaut C, Noblet C et al. Indirect drug-related costs. Lancet 1995 ; 345 : 588-589
16. Novack V, Jotkowitz A, Delgado J et al. General characteristics of hospitalized patients after deliberate self-poisoning and risk factors for intensive care admission. Eur J Intern Med 2006 ; 17 : 485-489
17. Olfson M, Gameroff MJ, Marcus SC et al. National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry 2005 ; 162 : 1328-1335
18. Otsubo T, Akimoto Y, Yamada H et al. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. Pharmacopsychiatry 2005 ; 38 : 30-35
19. Ott P, Dalhoff K, Hansen PB et al. Consumption, overdose and death from analgesics during a period of over-the-counter availability of paracetamol in Denmark. J Intern Med 1990 ; 227 : 423-428
20. Ruths FA, Tobiansky RI, Blanchard M. Deliberate self-harm (DSH) among older people: a retrospective study in Barnet, North London. Int J Geriatr Psychiatry 2005 ; 20 : 106-112
21. Shah R, Uren Z, Baker A et al. Deaths from antidepressants in England and Wales 1993 - 1997: analysis of a new national database. Psychol Med 2001 ; 31 : 1203-1210
22. Staikowsky F, Theil F, Mercadier P et al. Change in profile of acute self drug-poisonings over a 10-year period. Hum Exp Toxicol 2004 ; 23 : 507-511
23. Tournier M, Grolleau A, Cougnard A et al. Factors associated with choice of psychotropic drugs used for intentional drug overdose. Eur Arch Psychiatry Clin Neurosci 2008
24. Tournier M, Molimard M, Abouelfath A et al. Prognostic impact of psychoactive substances use during hospitalization for intentional drug overdose. Acta Psychiatr Scand 2005 ; 112 : 134-140
25. Tournier M, Molimard M, Abouelfath A et al. Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients. Acta Psychiatr Scand 2003 ; 108 : 410-418
26. Tournier M, Molimard M, Cougnard A et al. Psychiatric disorders and their comorbidity in subjects with parasuicide by intentional drug overdose: prevalence and gender diff erences. Psychiatry Res 2005 ; 136 : 93-100
27. Tournier M, Molimard M, Titier K et al. Accuracy of information on substance use recorded in medical charts of patients with intentional drug overdose. Psychiatry Res 2007 ; 152 : 73-79
28. Ulrich S, Hiemke C, Laux G et al. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientifi c evidence. Pharmacopsychiatry 2007 ; 40 : 121-127
29. WHO Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. In: Norwegian Institute of Public Health. Oslo, Norway ; 2007
30. Zemrak WR, Kenna GA. Association of antipsychotic and antidepressant drugs with Q-T interval prolongation. Am J Health Syst Pharm 2008 ; 65 : 1029-1038